Multicentric phase II trial of TI‐CE high‐dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multicentric phase II trial of TI‐CE high‐dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors

Published:2021-03-05 Issue:7 Volume:10 Page:2250-2258
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Chevreau Christine¹^ORCID,Massard Christophe²^ORCID,Flechon Aude³,Delva Rémy⁴,Gravis Gwenaëlle⁵,Lotz Jean‐Pierre⁶,Bay Jacques‐Olivier⁷,Gross‐Goupil Marine⁸,Fizazi Karim²,Mourey Loïc¹,Paci Angelo²,Guitton Jérôme⁹,Thomas Fabienne¹¹⁰^ORCID,Lelièvre Bénédicte¹¹,Ciccolini Joseph¹²,Moeung Sotheara¹¹⁰,Gallois Yohan¹³,Olivier Pascale¹,Culine Stéphane¹⁴,Filleron Thomas¹,Chatelut Etienne¹¹⁰

Affiliation:

1. Institut Claudius RegaudIUCT‐Oncopole Toulouse France

2. Institut Gustave Roussy Villejuif France

3. Centre Léon Bérard Lyon France

4. Institut de Cancérologie de l’Ouest Centre Paul Papin Angers France

5. Institut Paoli Calmettes Marseille France

6. Hôpital Tenon Paris France

7. CHU de Clermont‐Ferrand France

8. Hôpital Saint‐André Bordeaux France

9. Laboratoire de Pharmacologie ToxicologieCHU Lyon France

10. Cancer Research Center of Toulouse (CRCT),Université Paul Sabatier Toulouse France

11. Laboratoire de Pharmacologie Toxicologie CHU Angers France

12. CHU La Timone Marseille France

13. Service d'Otoneurologie et ORL Pédiatrique Hôpital Pierre Paul RiquetCHU de Toulouse Toulouse France

14. Hôpital Saint‐Louis Paris France

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3687

Reference20 articles.

1. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.

2. High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors

3. Salvage Treatment With Paclitaxel, Ifosfamide, and Cisplatin Plus High-Dose Carboplatin, Etoposide, and Thiotepa Followed by Autologous Stem-Cell Rescue in Patients With Relapsed or Refractory Germ Cell Cancer

4. A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission

5. Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ototoxicity associated with high‐dose carboplatin for patients with previously treated germ cell tumors;Cancer;2023-09-16

2. Therapeutic drug monitoring in oncology - What’s out there: A bibliometric evaluation on the topic;Frontiers in Oncology;2022-11-10

3. Hematopoietic stem cell mobilization strategies to support high-dose chemotherapy: A focus on relapsed/refractory germ cell tumors;World Journal of Clinical Oncology;2021-09-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3